Navigation Links
Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for,the Treatment of Obesity at the American Diabetes Association 67th,Scientific Session

PLYMOUTH MEETING, Pa., June 25, 2007 /PRNewswire-FirstCall/ -- Genaera Corporation today announced that data from a preclinical study of trodusquemine (MSI-1436) for the treatment of obesity were presented during the American Diabetes Association (ADA) 67th Scientific Sessions, June 22-25 in Chicago, IL. Dr. Kristen Lantz, Genaera research scientist and lead author of Abstract #1801-P, presented, "Trodusquemine is a Multiple Pathway Inhibitor that Causes Differential Weight Loss, Reduces Adiposity, and Improves Plasma Insulin and Leptin Levels."

The poster presentation summarizes results from preclinical studies demonstrating that trodusquemine suppresses appetite and causes differential weight loss in a mouse model of diet-induced obesity (DIO). Data presented also indicates that trodusquemine selectively inhibits PTP-1B, an enzyme central to controlling the function of both the leptin and insulin pathways. In addition, trodusquemine was shown to reduce the size of adipocytes, reduce body fat with no reduction of lean mass, and improve glucose tolerance via inhibition of a unique combination of signaling pathways in the DIO mouse model, making trodusquemine a promising therapeutic candidate.

"This preclinical data supports our current Phase 1 clinical strategy for trodusquemine as a treatment for obesity and further reinforces our belief that trodusquemine may also be successful in the treatment of type 2 diabetes," stated Jack Armstrong, President and Chief Executive Officer of Genaera. "We believe that, if successful, trodusquemine could be an effective monotherapy able to treat both obesity and type 2 diabetes, and could revolutionize the way these metabolic diseases are treated."

Scientists from Genaera will be available for discussion of the poster today from 12:00 p.m. to 2:00 p.m. Central Time in the Poster Hall at the conference.

For more information online, please visit: '"/>




Page: 1 2 3 4

Related medicine technology :

1. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
4. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
5. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
6. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
7. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. DiObex Presents Phase 2a Data of DIO-902 Demonstrating Trends of Improved Glycemic Control and Significant Reductions of LDL-Cholesterol and C-Reactive Protein
11. BioCryst Presents Phase I Peramivir Data at the Options for the Control of Influenza Conference

Post Your Comments:
(Date:11/6/2009)...PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC B... an Atlanta-based, biopharmaceutical company devel...(Human Immunodeficiency Virus) and other infectiou...inancial results and provided an operational updat...f Executive Officer commented, "We are pleased wit...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- Caraco Pharmaceutical Lab...torolac tromethamine ophthalmic solution, 0.5% fol...Administration (FDA) for Sun Pharma,s Abbreviated ...4; opthalmic solution on the first day following p...erapeutically equivalent to Acular® Ophthalmi...
(Date:11/6/2009)...er 6 , - Trial Will Compa...e,Treatment of Multi-Resistant Staphylococcus Aure...ity pharmaceutical company focused on the discover... overcome the significant global,problem of microb...nced oral,antibacterial NXL103 (flopristin/linopri...
Breaking Medicine Technology:GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Earliest animals lived in a lake environment research shows 9384 1Earliest animals lived in a lake environment research shows 9384 2Earliest animals lived in a lake environment research shows 9384 3Video shows nanotube spins as it grows 13221 1Video shows nanotube spins as it grows 13221 2Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday August 5 2009 52861 1Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday August 5 2009 52861 2Alexza to Announce 2009 Second Quarter Financial Results and Update Its Clinical Pipeline Status on Wednesday August 5 2009 52861 3
... patients for a clinical trial, another step in,th... new Mayo Clinic,study found that 40 percent of pa...es prior to their pancreatic cancer diagnosis. The...ome cases up to two years) prior to,cancer diagnos...tant clue,for earlier detection of pancreatic canc...
...an. 22 A new world-first study,by Monash Universi...as a,profound impact on one of society,s biggest h...oday in Journal of the American Medical,Associatio...s who underwent,gastric banding were five times mo... remission, compared with patients who engaged in ...
Other Medicine Technology:Mayo Clinic Study Finds Further Association Between Diabetes and Pancreatic Cancer 2Gastric Banding Reverses Impact of Type 2 Diabetes 2
(Date:11/6/2009)...-Three leading scientific organizations specializi...er to President Obama today expressing their signi...rning the use of personal protective equipment (PP...confirmed cases of 2009 H1N1 influenza. The Soci... the Infectious Diseases Society of America (IDSA)...
(Date:11/6/2009)..., clinic and government programs, expert says , ...ecession has made it more difficult than ever befo...ations, but several options are available, accordi...olis. , First, talk to your pharmacist, advised...nt professor of pharmacy practice at Butler,s Coll...
(Date:11/6/2009)...n doses now available, with 8 million more due nex...ews) -- Although the total doses of H1N1 swine flu...8 million -- 11 million more than a week ago -- mo...le to get one, U.S. health officials acknowledged ...percent of children who tried to get vaccinated co...
(Date:11/6/2009)... Mich., Nov. 6 Two additional larg...uled by the Macomb County Health Department, the d...eedom Hill County Park in Sterling Heights Saturda...ill is located at 14900 Metropolitan Parkway. At l...at each of these clinics. Both the nasal spray and...
(Date:11/6/2009)... Nov. 6 With the number of prematu...sing in the U.S., a basic eye exam, including a re...rtly after birth, reports Angela Buffenn, M.D., M....tute at The Vision Center of Childrens Hospital Lo...d many medically fragile infants to survive. Unfor...
Breaking Medicine News(10 mins):Health News:Prevention experts urge modification to 2009 H1N1 guidance for health care workers 2Health News: Pay Less for Prescription Drugs 2Health News:Most Who Want Swine Flu Shot Can't Get It 2Health News:Most Who Want Swine Flu Shot Can't Get It 3Health News:Macomb County Announces Two Additional Communitywide H1N1 Flu Vaccine Clinics Saturday, Nov. 14 and 21; Clinic For Health Care Workers Only Set For Nov. 12 2Health News:Red Reflex Vision Exam Should Be Given to All Newborns, Report Recommends 2Health News:Red Reflex Vision Exam Should Be Given to All Newborns, Report Recommends 3
...Science Award from Keio University in Tokyo. Mr. ...cs and Biochemistry// at Yale, received the award ...d by the University on November 1 2006. The aw...rded by a Japanese University. It included an hono...
...s National University Hospital to detect cancer in... The hospital is conducting a trial involving 58 ... the "optical biopsy" diagnosed them with early-st...ears, the usual method used to test for cancer in ...
...225 in 2003 to 66 in 2005. However there is a spur... which has further spread not// only to other part...yana, Punjab,Chandigarh, Madhya Pradesh and Mahara... of polio was reviewed by India ExpertAdvisory Gro...
...s of previous health campaigns on AIDS and smoking...res to combat the// growing obesity problem in Aus...to curb obesity will not meet the desired result, ...omething that has come upon us with alarming speed...
... Chikunguniya in Sri lanka has been confirmed by h...be infected.// Symptoms of Chikungunya are h..., body ache and vomiting in some cases. Health exp... dengue fever as monsoon rains have created breedi...
... children and families has thrown new light on why...o produce results needed// for overcoming the pres...inding is contained in the fourth volume of result...titute for Child Health Research, analysed data fr...
Other Medicine News:Health News:Yale Scientist Received Medical Science Prize From Keio University 2Health News:Increase in Polio Cases 2Health News:Chikungunya Reaches Sri Lanka 2Health News:Research Focus on the Ineffectiveness of Programs for Aboriginal children 2Health News:Research Focus on the Ineffectiveness of Programs for Aboriginal children 3
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: